• Home
  • News
  • Portfolio News
  • Akston Biosciences Doses First Subjects in Phase II Clinical Trial in India of Second-Generation COVID-19 Vaccine

Akston Biosciences Doses First Subjects in Phase II Clinical Trial in India of Second-Generation COVID-19 Vaccine

21Nov

Akston Biosciences Doses First Subjects in Phase II Clinical Trial in India of Second-Generation COVID-19 Vaccine

Portfolio News

Akston Biosciences Corporation, a developer of new classes of biologic therapeutics, announced today that the first of 100 subjects were dosed in an open-label bridging study of AKS-452, its protein subunit COVID-19 vaccine candidate, in India. Read more >>

Share this post

Related Posts

09Feb

eSight and Be My Eyes Announce Winner of their eSight 4 Sweepstakes

Leading vision-enhancement platform, eSight, and Be My Eyes, a community-based virtual assistance platform, today announce the recipient of their eSight... read more
29Mar

Free Online Practice SAT and ACT Test Sessions on Saturdays

Boston-based SAT/ACT prep organization Testive, Inc. is offering its popular proctored practice SATs and ACTs for free online, every Saturday... read more
16Dec

Researchers Genetically Program B Cells to Treat Genetic Disorder

A Seattle-based biotech company is conducting a trial using genetically programmed B cells to treat a genetic disorder called mucopolysaccharidosis... read more
21Aug

4th Annual IPF Summit

Xylyx Bio. to speak at the 4th Annual IPF Summer. Read more >> read more
30Sep

Zylö’s ‘Powered By Z-pod’ Technology Featured in Peer-Reviewed Paper Published in Experimental Dermatology

The Z-pod® topical delivery platform was used in various in vivo studies that were highlighted in a peer-reviewed paper just... read more
13Mar

The Death of the RFP: A Dream Come True for Advertisers

Media buyers and planners continue to suffer the guessing game of the RFP but not for long. Mollie Kehoe and... read more
21Nov

Kalion completes first full-scale glucaric acid fermentation

The industrial biotech start-up Kalion says it has collected several tons of glucaric acid from its first full-scale fermentation, conducted... read more
23Jan

Startup gives cash back rewards to pay down student debt

Startup FutureFuel.io is partnering with retailers to combat student debt. FutureFuel.io Founder & CEO Laurel Taylor joins Yahoo Finance's Zack... read more
10Jul

Myomo Appoints Micah Mitchell as Chief Commercial Officer

Myomo, Inc., a wearable medical robotics company, announced today that Micah Mitchell is joining the company as chief commercial officer... read more
11Sep

Rapid Lyme test developed at Cornell could be ‘major breakthrough’ in treatment

The test would quickly confirm the presence of the bacteria that causes Lyme, rather than waiting for weeks for a... read more